1-3 of 3
Jörg Kreuzer, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dabigatran Etexilate in Children with Venous Thromboembolism: Results of the Open-Label, Phase IIb/III, Randomized Diversity Clinical Trial

Free
Jacqueline Halton, MD, Leonardo R. Brandao, MD, Matteo Luciani, MD, Lisa Bomgaars, MD, Elizabeth Chalmers, MD, Lesley Mitchell, MD, Ildar Nurmeev, MD, Anjali Sharathkumar, MD, Pavel Svirin, MD, Kirill Gorbatikov, MD, Igor Tartakovsky, MD, Monika Simetzberger, DI, Fenglei Huang, PhD, Zhichao Sun, PhD, Jörg Kreuzer, MD, Savion Gropper, MD, Martina Brueckmann, MD, Manuela Albisetti, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 24–25.
https://doi.org/10.1182/blood-2020-136682
Published: 2020
Journal Articles

Dabigatran Is Associated with a Significantly Lower Risk of Abnormal Uterine Bleeding Than Warfarin in Female Patients of Childbearing Age with Venous Thromboembolism

Free
Melanie Ferreira, Frederikus A Klok, Martin Feuring, Mandy Fraessdorf, Jörg Kreuzer, MD, Menno V Huisman
Journal: Blood
Blood (2016) 128 (22): 140.
https://doi.org/10.1182/blood.V128.22.140.140
Published: 2016
Journal Articles

Dabigatran Etexilate or Warfarin in the Treatment of Acute Venous Thromboembolism in Western European Patients: A Pooled Analysis of RE-COVER ® and RE-COVER II™

Free
Sebastian Schellong, MD, Henry Eriksson, MD PhD, Samuel Z. Goldhaber, MD, Martin Feuring, MD, Stefan Hantel, PhD, Jörg Kreuzer, MD, Sam Schulman, MD PhD, Ajay K Kakkar, MB, BS, PhD
Journal: Blood
Blood (2015) 126 (23): 4730.
https://doi.org/10.1182/blood.V126.23.4730.4730
Published: 2015